Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mutant BR96 antibodies reactive with human carcinomas

Mutant BR96 antibodies reactive with human carcinomas

US Patent 5728821 · Granted Mar 17, 1998

Estimated economic value: $696,565,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CCR7 antibody drug conjugates2024
ENTPD2 antibodies, combination therapies, and methods of using the antibodies an2024
mRNA-mediated immunization methods2024
Anti-CCR7 antibody drug conjugates2023
Linker peptides and polypeptides comprising same2016
Stabilized polypeptide compositions2014
Light targeting molecules and uses thereof2014
Modified binding molecules comprising connecting peptides2013
Method for producing polymers having a preselected activity2012
High potency recombinant antibodies and method for producing them2012
Anti-IGR-1R antibodies and uses thereof2012
Multispecific binding molecules comprising connecting peptides2011